4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001831410-25-000007
Director sold 2,881 shares at $28.53 ($82,195)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2025-12-22 | Sale | −2,881 | $28.53 | $82,195 | 741,259 | D: show line 1 in the form |
| Open-market sales · 2,881 sh · avg $28.53 · $82,195 | |||||||
Loading xslF345X05/form4-12292025_091201.xml…